Utah Medical Net Income Per E B T Over Time
| UTMD Stock | USD 63.62 0.22 0.34% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Utah Medical Performance and Utah Medical Correlation. Utah |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 1.2 | Earnings Share 4.28 | Revenue Per Share 12.392 | Quarterly Revenue Growth (0.20) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Per E B T Analysis
Compare Utah Medical Products and related stocks such as Precision Optics,, Repro Med Systems, and InfuSystems Holdings Net Income Per E B T Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POCI | 0.5 | 0.9991 | 1.0005 | 1.0008 | 1.0008 | 1.0009 | 1.0009 | 1.0026 | 1.0015 | 1.0015 | 1.0089 | 1.001 | 1.0136 | 1.0007 | 0.79 |
| KRMD | 1.0015 | 0.6991 | 0.6991 | 0.6962 | 0.7009 | 0.6888 | 0.6888 | 0.6921 | 0.7737 | 0.8104 | 1.0149 | 0.7169 | 0.8113 | 1.4059 | 1.01 |
| INFU | 1.1521 | 0.6627 | 0.6919 | 0.6181 | 0.5406 | 0.6716 | 0.6099 | 3.9389 | 1.0509 | 0.893 | 2.2978 | 1.1297 | 0.1385 | 0.4711 | 0.82 |
| MLSS | 0.9048 | 1.0976 | 1.0024 | 1.0024 | 1.0024 | 1.7878 | 0.9124 | 0.9917 | 0.9291 | 1.0024 | 1.0021 | 1.0 | 0.9924 | 0.9926 | 1.19 |
| PDEX | 0.9231 | 0.6253 | 0.9375 | 0.6464 | 0.8184 | 0.9705 | 1.8474 | 0.6211 | 0.7615 | 0.7735 | 0.791 | 0.9715 | 0.7503 | 0.8075 | 0.64 |
| LMAT | 1.005 | 0.5712 | 0.6439 | 0.7398 | 0.6195 | 0.6791 | 0.652 | 0.8138 | 0.8066 | 0.8273 | 0.7757 | 0.7848 | 0.7507 | 0.7626 | 0.92 |
| ANGO | 0.6173 | 0.9644 | 0.9519 | 0.484 | 0.4086 | 10.2069 | 0.5915 | 2.1882 | 1.0315 | 0.9919 | 0.8751 | 0.8864 | 0.9634 | 0.962 | 0.94 |
| ATRC | 1.0037 | 1.0057 | 1.0067 | 1.0016 | 1.002 | 1.0013 | 1.0012 | 1.0005 | 1.0108 | 1.0057 | 1.0024 | 0.9963 | 1.0058 | 1.0198 | 1.11 |
| AKYA | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0133 | 1.0025 | 0.9967 | 1.0017 | 1.0006 | 1.1 |
| ATR | 0.629 | 0.6681 | 0.6737 | 0.6505 | 0.6694 | 0.6767 | 0.7329 | 0.7463 | 0.7321 | 0.7081 | 0.7107 | 0.7589 | 0.7149 | 0.759 | 0.54 |
| ICUI | 2.7273 | 0.6725 | 0.6676 | 0.7667 | 0.6618 | 0.6454 | 0.7407 | 1.3385 | 1.2869 | 0.8808 | 0.891 | 0.8372 | 0.6493 | 0.3787 | 0.36 |
| MMSI | 0.7647 | 0.701 | 0.7137 | 0.8352 | 0.7277 | 0.7629 | 0.7926 | 0.7671 | 0.8485 | 2.4856 | 0.7439 | 0.8987 | 0.9018 | 0.8423 | 0.62 |
Utah Medical Products and related stocks such as Precision Optics,, Repro Med Systems, and InfuSystems Holdings Net Income Per E B T description
My Equities
My Current Equities and Potential Positions
| Utah Medical Products | UTMD |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Utah; U.S.A |
| Exchange | NASDAQ Exchange |
USD 63.62
Check out Utah Medical Performance and Utah Medical Correlation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Utah Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.